Aurobindo Pharma Limited AUROPHARMA.NS Stock
Aurobindo Pharma Limited Price Chart
Aurobindo Pharma Limited AUROPHARMA.NS Financial and Trading Overview
| Aurobindo Pharma Limited stock price | 1093.3 INR |
| Previous Close | 685.4 INR |
| Open | 689.85 INR |
| Bid | 679.4 INR x 0 |
| Ask | 679.25 INR x 0 |
| Day's Range | 676.1 - 689.85 INR |
| 52 Week Range | 397.2 - 690 INR |
| Volume | 957.13K INR |
| Avg. Volume | 1.96M INR |
| Market Cap | 398.44B INR |
| Beta (5Y Monthly) | 0.434246 |
| PE Ratio (TTM) | 20.3167 |
| EPS (TTM) | 47.24 INR |
| Forward Dividend & Yield | 9 (1.34%) |
| Ex-Dividend Date | February 17, 2023 |
| 1y Target Est | 953 INR |
AUROPHARMA.NS Valuation Measures
| Enterprise Value | 383.08B INR |
| Trailing P/E | 20.3167 |
| Forward P/E | 10.91668 |
| PEG Ratio (5 yr expected) | 1.18 |
| Price/Sales (ttm) | 1.6030273 |
| Price/Book (mrq) | 1.4845573 |
| Enterprise Value/Revenue | 1.541 |
| Enterprise Value/EBITDA | 10.193 |
Trading Information
Aurobindo Pharma Limited Stock Price History
| Beta (5Y Monthly) | 0.434246 |
| 52-Week Change | 32.89% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 690 INR |
| 52 Week Low | 397.2 INR |
| 50-Day Moving Average | 614.83 INR |
| 200-Day Moving Average | 513.93 INR |
AUROPHARMA.NS Share Statistics
| Avg. Volume (3 month) | 1.96M INR |
| Avg. Daily Volume (10-Days) | 1.13M INR |
| Shares Outstanding | 585.94M |
| Float | 281.41M |
| Short Ratio | N/A |
| % Held by Insiders | 52.02% |
| % Held by Institutions | 23.41% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 68.00% |
| Payout Ratio | 0.22799999 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 7.75% |
| Operating Margin (ttm) | 10.11% |
| Gross Margin | 54.56% |
| EBITDA Margin | 15.12% |
Management Effectiveness
| Return on Assets (ttm) | 4.25% |
| Return on Equity (ttm) | 7.49% |
Income Statement
| Revenue (ttm) | 248.55B INR |
| Revenue Per Share (ttm) | 424.25 INR |
| Quarterly Revenue Growth (yoy) | 11.40% |
| Gross Profit (ttm) | 135.62B INR |
| EBITDA | 37.58B INR |
| Net Income Avi to Common (ttm) | 19.27B INR |
| Diluted EPS (ttm) | 33.47 |
| Quarterly Earnings Growth (yoy) | -12.19% |
Balance Sheet
| Total Cash (mrq) | 62.35B INR |
| Total Cash Per Share (mrq) | 106.41 INR |
| Total Debt (mrq) | 52.86B INR |
| Total Debt/Equity (mrq) | 19.69 INR |
| Current Ratio (mrq) | 1.875 |
| Book Value Per Share (mrq) | 458.049 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 23.87B INR |
| Levered Free Cash Flow (ttm) | -4711349760 INR |
Profile of Aurobindo Pharma Limited
| Country | India |
| State | N/A |
| City | Hyderabad |
| Address | Galaxy, Plot No. 1 |
| ZIP | 500032 |
| Phone | 91 40 6672 5000 |
| Website | https://www.aurobindo.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
Q&A For Aurobindo Pharma Limited Stock
What is a current AUROPHARMA.NS stock price?
Aurobindo Pharma Limited AUROPHARMA.NS stock price today per share is 1093.3 INR.
How to purchase Aurobindo Pharma Limited stock?
You can buy AUROPHARMA.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aurobindo Pharma Limited?
The stock symbol or ticker of Aurobindo Pharma Limited is AUROPHARMA.NS.
Which industry does the Aurobindo Pharma Limited company belong to?
The Aurobindo Pharma Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aurobindo Pharma Limited have in circulation?
The max supply of Aurobindo Pharma Limited shares is 585.94M.
What is Aurobindo Pharma Limited Price to Earnings Ratio (PE Ratio)?
Aurobindo Pharma Limited PE Ratio is 23.14352200 now.
What was Aurobindo Pharma Limited earnings per share over the trailing 12 months (TTM)?
Aurobindo Pharma Limited EPS is 47.24 INR over the trailing 12 months.
Which sector does the Aurobindo Pharma Limited company belong to?
The Aurobindo Pharma Limited sector is Healthcare.